COLORADO WORKS BETTER™ Taxpayer Shareholder Portal Follow

Who runs this

Works Better Corporation, a nonpartisan public benefit corporation, builds this site.

Independent public-records project, separate from the State of Colorado and from every party and campaign.

Every number carries one of four labels (FACT, CALC, SAMPLE or PENDING) and a source you can open.

Patient Access to Compounded Medical Items

Concerning preserving patient access to compounded medical items.

HB26-1262 2026 Regular Session Signed into Law Health Care & Health Insurance Professions & Occupations

Cost estimates

At the first note read
$0
FACT March 3, 2026
At the last note read
$0
FACT August 27, 2026
What it actually cost
not published
No Colorado source reports spending for one bill

Every figure here is an estimate by Legislative Council Staff on the date shown, about the version of the bill in front of them that day. It is not a cost.

The appropriation

The note states no appropriation is required.

An appropriation is money the legislature sets aside. It is not money spent.

The appropriation field, read from the note: No appropriation is required.

Bill summary

     The act provides that, if the action is undertaken in accordance with applicable federal and state law:

  • A licensed person may compound a drug or device in the state;
  • A state-licensed pharmacy or a distribution facility registered with the federal food and drug administration (licensed 503B outsourcing facility) may supply a compounded drug or device to a licensed health-care provider, pharmacy, facility, or organization; and
  • A licensed health-care provider, pharmacy, facility, or organization may obtain, dispense, or administer a compounded drug or device supplied by a state-licensed pharmacy or a licensed 503B outsourcing facility.

     In addition, the act prohibits the state board of pharmacy from adopting rules that are more restrictive than federal or state law regarding the compounding of drugs or devices by licensed 503B outsourcing facilities.

     Current law exempts drugs that are intended solely for investigational use by experts qualified by scientific training and experience and that are plainly labeled for investigational use only from the sales and delivery prohibition for new drugs. The act also exempts from the prohibition:

  • Drugs that are reviewed by an institutional review board and plainly labeled for investigational use only; and
  • Compounded drugs and devices if the compounding of the drug or device is undertaken in accordance with applicable federal and state law.

FACT Bill summary by Colorado Legislative Council Staff, read 2026-09-23. Printed as published, word for word. Source: leg.colorado.gov (opens in a new tab)